<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>12</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Weiss, Rick</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Time to sweat the small stuff</style></title><secondary-title><style face="normal" font="default" size="100%">Science Progress Blog</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 25, 2008</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scienceprogress.org/2008/07/time-to-sweat-the-small-stuff/</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">With the advances already happening in the use of nanotechnology in health care, and the promise of using this technology to find new ways of treating diseases like cancer, the author takes a look at the extremely slow progress being made by the U.S. Food and Drug Administration (FDA) in examining if the current criteria for determining the safety and efficacy of new drugs can deal with the unique properties of nanomaterials. The author comments on the lack of progress being made, and calls for a more focused attention on this issue in the near future.</style></abstract><work-type><style face="normal" font="default" size="100%">Blog entry</style></work-type></record></records></xml>